Home

OLIVIER BRANDICOURT

CIK 1508518 · Business Unit President · last filed 2026-06-16

OLIVIER BRANDICOURT is a Business Unit President who has filed 76 SEC Form 4 insider transactions across 5 companies since 2011. The most recent filing, for PCVX, was dated Jun 16, 2026. Across all open-market trades the lifetime net is −$3.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $26.4M across reported positions. 9 SEC filings were submitted jointly with PFIZER INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$26.43M

Companies

5

Total Filings

76

Lifetime Open-Market Net

-$3.19M

Filer Profile

Reported Address
675 WEST KENDALL STREET
HENRI A. TERMEER SQUARE
CAMBRIDGE, MA 02142
Related Filers
PFIZER INC — 9 joint filings, latest 2013-11-04
ALNYLAM PHARMACEUTICALS, INC. — 8 joint filings, latest 2026-05-22
BeiGene, Ltd. — 5 joint filings, latest 2026-06-15
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PCVX Director 4,699 $56.65 $266.2K $0 4 2026-06-16
ONC Director 46,306 $362.19 $16.77M $0 2 2026-06-15
ALNY Director 1,446 $255.93 $370.1K $0 7 2026-05-22
BeOne Medicines Ltd. (BGNE) Delisted Director 16,341 $184.71 $3.02M $0 2 2024-06-07
PFE Business Unit President 315,124 $28.62 $9.02M -$3.19M 61 2013-11-04

Recent Filings

76 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-16 PCVX Grant (A) +2,194 $0 EDGAR
2026-06-15 ONC Grant (A) +18,980 $0 EDGAR
2026-05-22 ALNY Grant (A) +671 $0 EDGAR
2026-01-16 PCVX Grant (A) +1,357 $0 EDGAR
2025-06-16 PCVX Grant (A) +1,148 $0 EDGAR
2025-05-22 ONC Grant (A) +10,985 $0 EDGAR
2025-05-12 ALNY Grant (A) +775 $0 EDGAR
2025-05-02 PCVX Grant (A) — $0 EDGAR
2024-06-07 BeOne Medicines Ltd. (BGNE) Delisted Grant (A) +16,341 $0 EDGAR
2024-05-20 ALNY Grant (A) — $0 EDGAR
Showing 1–10 of 76
Page 1 of 8
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.